论文部分内容阅读
目的研究肿瘤标志物和生化指标联合检测在鉴别良、恶性胸腹水中的价值.方法根据胸腹水来源将107例胸腹水患者标本分为肝硬化组、感染性疾病组和肿瘤组,对三组患者的总蛋白、腺苷脱氢酶、乳酸脱氢酶、CA125等指标进行检测并进行组间分析.结果肿瘤组患者TP、LDH、ADA、CA125等指标明显高于肝硬化组(P<0.05).感染性疾病组ADA、TP和LDH的含量与肝硬化组差异明显(P<0.05),而感染性疾病组的ADA和CA125与肿瘤组有明显差异(P<0.05).结论 TP、ADA、CA125和LDH的联合检测对鉴别肝硬化、感染性疾病和肿瘤来源的胸腹水有一定的参考价值.
Objective To study the value of combined detection of tumor markers and biochemical markers in the differential diagnosis of benign and malignant ascites and hydrothorax.Methods According to the source of ascites and hydrothorax, 107 patients with ascites and pleural effusion were divided into cirrhosis group, infectious disease group and tumor group, The levels of total protein, adenosine dehydrogenase, lactate dehydrogenase and CA125 were detected and analyzed between groups.Results The indexes of TP, LDH, ADA and CA125 in the tumor group were significantly higher than those in the cirrhosis group (P <0.05) ), ADA, TP and LDH levels in infectious disease group were significantly different from those in cirrhosis group (P <0.05), while ADA and CA125 in infectious disease group were significantly different from those in the control group (P0.05) .Conclusion TP, ADA The combined detection of CA125 and LDH has certain reference value for the identification of cirrhosis, infectious diseases and pleural effusion of tumor origin.